Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biohaven
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
2
×
rimegepant
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
acc
acquisition
activist investor
aducanumab
alder biopharmaceutical
allergan
alzheimer's failure
american academy of neurology
american college of cardiology
amgen
amyloid
What
drug
adu
approval
approved
arguments
beats
bids
big
bio
biogen
class
commercialized
companies
competitors
complicated
decades
depression
dire
drugs
fda
good
group
heart
help
make
medical
meeting
migraine
need
neuro
new
news
oral
people
postpartum
potential
relief
roundup
sage
therapies
Language
Current search:
biohaven
×
photo
×
" texas blog main "
×
" raleigh-durham top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More